CD8A and neoplasm: Additionally, IL-10 fusion proteins, such as IL-10/Fc constructs, have shown potential in prolonging IL-10’s half-life, while minimizing systemic exposure, and in reinvigorating exhausted CD8+ TILs, thereby enhancing tumor-specific immune responses [65].